Canaccord Genuity initiated coverage on Olink Holding with a new price target
$OLK
Biotechnology: Laboratory Analytical Instruments
Industrials
Canaccord Genuity initiated coverage of Olink Holding with a rating of Buy and set a new price target of $28.00